This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pharmacyclics Inc (PCYC)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Jun 2012
Cash and Equivalents 845.04M 623.96M 307.43M 197.90M
Receivables 91.27M 63.00M 26.70M 6.01M
Inventories 34.45M 12.60M 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 1.02B 740.80M 346.49M 213.40M
Property, Plant & Equipment, Gross 44.05M 33.19M 14.97M 12.32M
Accumulated Depreciation & Depletion 11.58M 7.72M 8.57M 8.48M
Property, Plant & Equipment, Net 32.48M 25.47M 6.40M 3.84M
Intangibles 8.73M 0.00 0.00 0.00
Other Non-Current Assets 3.34M 2.48M 2.23M 1.88M
Total Non-Current Assets 44.55M 27.95M 8.64M 5.72M
Liabilities & Shareholder Equity
Total Assets 1.06B 768.75M 355.13M 219.12M
Accounts Payable 87.11M 7.41M 4.61M 9.18M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 70.00K 8.49M 1.39M 0.00
Total Current Liabilities 194.24M 87.63M 29.26M 18.99M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 36.71M 53.50M 63.35M 68.01M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 36.71M 53.50M 63.35M 68.01M
Total Liabilities 230.94M 141.13M 92.60M 87.00M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 829.16M 627.62M 262.53M 132.12M
Common Par 8.00K 7.00K 7.00K 7.00K
Additional Paid In Capital 959.64M 844.22M 546.13M 533.26M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -130.47M -216.60M -283.61M -401.14M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -8.00K -8.00K -4.00K -9.00K
Total Capitalization 829.16M 627.62M 262.53M 132.12M
Total Equity 829.16M 627.62M 262.53M 132.12M
Total Liabilities & Stock Equity 1.06B 768.75M 355.13M 219.12M
Total Common Shares Outstanding 75.93M 74.17M 70.22M 69.32M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 75.25M 72.78M 69.68M 68.73M
Diluted Weighted Shares Outstanding 78.15M 77.08M 74.41M 72.62M
Number of Employees 607 484 224 150
Number of Part-Time Employees 0 0 0 0

PCYC Pharmacyclics Inc

Analysts Ratings for PCYC

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 7
Moderate Buy 0 0 0 0
Hold 9 10 11 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

PCYC Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs